🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/10/2016 | 112,07 | 112,85 | 111,11 | 112,17 | +0,33% | 1,55% | 651.900 |
| 24/10/2016 | 112,39 | 113,30 | 111,57 | 111,80 | +0,11% | 1,54% | 426.300 |
| 21/10/2016 | 113,36 | 114,94 | 110,90 | 111,68 | -1,20% | 3,56% | 661.800 |
| 20/10/2016 | 115,79 | 116,79 | 111,11 | 113,04 | -2,95% | 4,91% | 889.400 |
| 19/10/2016 | 117,20 | 118,73 | 115,01 | 116,48 | -0,42% | 3,17% | 687.500 |
| 18/10/2016 | 118,34 | 119,65 | 116,86 | 116,97 | -0,45% | 2,36% | 392.100 |
| 17/10/2016 | 116,41 | 118,41 | 116,05 | 117,50 | +0,52% | 2,03% | 365.000 |
| 14/10/2016 | 118,48 | 119,99 | 116,03 | 116,89 | -0,60% | 3,34% | 545.800 |
| 13/10/2016 | 116,25 | 119,05 | 116,00 | 117,59 | +0,00% | 2,62% | 453.400 |
| 12/10/2016 | 120,84 | 121,92 | 117,49 | 117,59 | -2,91% | 3,67% | 571.600 |
| 11/10/2016 | 124,00 | 124,00 | 120,45 | 121,11 | -2,77% | 2,86% | 417.000 |
| 10/10/2016 | 124,14 | 125,29 | 123,71 | 124,56 | +0,84% | 1,27% | 290.000 |
| 07/10/2016 | 121,14 | 123,74 | 120,43 | 123,52 | +1,90% | 2,73% | 487.400 |
| 06/10/2016 | 121,60 | 121,93 | 119,78 | 121,22 | -0,20% | 1,77% | 396.800 |
| 05/10/2016 | 118,03 | 121,68 | 117,60 | 121,46 | +3,58% | 3,46% | 484.000 |
| 04/10/2016 | 118,92 | 119,42 | 116,56 | 117,26 | -0,91% | 2,40% | 312.400 |
| 03/10/2016 | 117,85 | 118,54 | 117,01 | 118,34 | +0,22% | 1,30% | 519.600 |
| 30/09/2016 | 115,84 | 118,36 | 114,38 | 118,08 | +2,66% | 3,44% | 738.700 |
| 29/09/2016 | 118,55 | 119,08 | 115,02 | 115,02 | -3,08% | 3,42% | 589.800 |
| 28/09/2016 | 121,76 | 122,22 | 116,70 | 118,67 | -2,74% | 4,53% | 884.300 |
| 27/09/2016 | 125,43 | 125,88 | 120,45 | 122,01 | -2,84% | 4,33% | 936.100 |
| 26/09/2016 | 126,30 | 126,76 | 125,13 | 125,57 | -1,29% | 1,29% | 376.100 |
| 23/09/2016 | 126,54 | 127,79 | 125,73 | 127,21 | +0,16% | 1,63% | 489.800 |
| 22/09/2016 | 123,88 | 127,18 | 123,05 | 127,01 | +2,87% | 3,33% | 731.300 |
| 21/09/2016 | 124,17 | 124,67 | 122,06 | 123,47 | +0,02% | 2,10% | 680.900 |
| 20/09/2016 | 123,64 | 124,50 | 122,02 | 123,44 | +0,55% | 2,01% | 593.400 |
| 19/09/2016 | 124,00 | 124,33 | 122,52 | 122,76 | -0,45% | 1,46% | 723.800 |
| 16/09/2016 | 122,17 | 124,62 | 122,17 | 123,31 | +0,43% | 2,01% | 878.900 |
| 15/09/2016 | 122,30 | 123,29 | 120,44 | 122,78 | +0,20% | 2,33% | 494.400 |
| 14/09/2016 | 122,51 | 123,83 | 121,55 | 122,53 | +0,59% | 1,86% | 343.800 |